For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Buscar Close Search
Buscar Close Search
Page Menu

Step 1 | 10 Reproductive System

10.1     Normal processes

10.1.1  embryonic development, fetal maturation, and perinatal changes

10.1.2  organ structure and function

10.1.2.1   female structure, including breast
10.1.2.2   female function (eg, menstrual cycle, puberty, menopause)
10.1.2.3   male structure
10.1.2.4   male function (eg, spermatogenesis, puberty)
10.1.2.5   intercourse, orgasm
10.1.2.6   pregnancy, ovulation, fertilization, implantation, including labor and delivery, the puerperium, lactation, gestational uterus, placenta

10.1.3  cell/tissue structure and function, including hypothalamic-pituitary-gonadal axis, sex steroids, gestational hormones

10.1.4  reproductive system defense mechanisms and normal flora

10.2     Abnormal processes

10.2.1  infectious, inflammatory, and immunologic disorders

10.2.1.1   infectious disorders (eg, toxic shock syndrome, breast abscess, orchitis)

10.2.1.1.1   sexually transmitted diseases

10.2.1.2   immunologic and inflammatory disorders (eg, autoimmune hypogonadism, cystic mastitis)

10.2.2  traumatic and mechanical disorders

10.2.2.1   female incontinence, prolapse, cystocele
10.2.2.2   torsion of testis, varicocele, circumcision, phimosis

10.2.3  neoplastic disorders

10.2.3.1   female reproductive (eg, cervix, ovary)
10.2.3.2   male reproductive (eg, prostate)
10.2.3.3   breast, including fibrocystic changes
10.2.3.4   trophoblastic disease

10.2.4  metabolic and regulatory processes

10.2.4.1   female (eg, anovulation, infertility, polycystic ovaries, endometriosis, orgasmic dysfunction, delayed and premature puberty)

10.2.4.1.1   menopausal syndrome

10.2.4.2   male (eg, infertility, impotence, gynecomastia, delayed and premature puberty)

10.2.4.2.1   benign prostatic hyperplasia

10.2.5  systemic disorders affecting reproductive function (eg, obesity, myotonic dystrophy, cirrhosis, renal failure)

10.2.6  Reserved

10.2.7  disorders relating to pregnancy, the puerperium, and the postpartum period

10.2.7.1   obstetric problems (eg, ectopic pregnancy, third-trimester bleeding)
10.2.7.2   complications affecting other organ systems (eg, eclampsia, gestational diabetes, thyroid disorders)
10.2.7.3   disorders associated with the puerperium (eg, postpartum hemorrhage, sepsis, depression)
10.2.7.4   antepartum, intrapartum, postpartum disorders of the fetus (eg, prematurity, postmaturity, cord compression, macrosomia)

10.3     Principles of therapeutics

10.3.1  mechanisms of action, use, and adverse effects of drugs for treatment of disorders of the reproductive system and management of normal reproductive function

10.3.1.1   female reproductive tract

10.3.1.1.1   fertility drugs
10.3.1.1.2    oral contraception, other methods of contraception (eg, condoms)
10.3.1.1.3    estrogen, progestogen replacement, treatment of menopause
10.3.1.1.4   stimulants and inhibitors of labor
10.3.1.1.5   estrogen and progesterone antagonists
10.3.1.1.6   stimulators and inhibitors of lactation

10.3.1.2   male reproductive tract

10.3.1.2.1   fertility drugs
10.3.1.2.2   androgen replacement and antagonists

10.3.1.3   gonadotropin-releasing hormone and gonadotropin replacement

10.3.1.4   abortifacients

10.3.1.5   antimicrobials

10.3.1.6   antineoplastics

10.3.1.7   restoration of potency

10.3.2  other therapeutic modalities affecting the reproductive system (eg, tampons)

 

10.4     Gender, ethnic, and behavioral considerations affecting disease treatment and prevention, including psychosocial, cultural, occupational, and environmental

10.4.1  emotional and behavioral factors (eg, sexually transmitted diseases)

10.4.2  influence on person, family, and society (eg, infertility)

10.4.3  occupational and other environmental risk factors (eg, radiation)

10.4.4  family planning and pregnancy (eg, unwanted)

10.4.5  gender identity, sexual orientation, sexuality, libido

10.4.6  effects of traumatic stress syndrome, violence, rape, child abuse